Rubius Therapeutics Inc. (RUBY)

AI Score

Unlock

0.06

0.00 (8.11%)

At close: Dec 29, 2023, 8:49 PM

Rubius Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017
Period Ending	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017
Cash & Equivalents	14.87M	103.88M	62.21M	98.1M	225.85M	264.02M	283.23M	288.09M	91.17M	75.17M	129.16M	144.52M	91.9M	109.61M	141.08M	192.5M	307.06M	354.79M	181.73M	136.47M	104.29M
Short-Term Investments	4.07M	n/a	78.5M	78.41M	n/a	n/a	15.01M	42.56M	85.12M	132.73M	107.37M	96.87M	191.39M	215.08M	221.25M	186.41M	96.99M	54.09M	64.81M	56.15M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	50K	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.88M	1.88M	2.05M	2.06M	2.09M	2.12M	1.84M	1.87M	1.9M	1.1M	3.59M	1.9M	284K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.26M	6.94M	81.28M	81.94M	3.98M	6.45M	21.05M	48.17M	90.35M	139.19M	114.91M	101.36M	197.37M	220.15M	4.32M	6.92M	10.36M	3.61M	1.09M	960K	700K
Total Current Assets	20.2M	110.82M	143.49M	180.04M	229.82M	270.47M	304.29M	336.26M	181.51M	214.36M	244.07M	245.88M	289.27M	329.76M	366.65M	385.83M	414.41M	412.49M	182.82M	193.58M	104.99M
Property-Plant & Equipment	2.83M	58.3M	84.02M	85.51M	86.63M	89.02M	90.22M	92.4M	94.4M	96.12M	98.31M	100.38M	103.48M	100.39M	69.54M	53.76M	62.8M	39.21M	21.13M	14.25M	2.42M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.88M	59.87M	85.59M	87.08M	88.2M	90.6M	91.8M	93.97M	96.28M	98M	100.36M	102.44M	105.58M	102.51M	71.38M	55.64M	64.7M	40.31M	24.72M	16.15M	2.7M
Total Assets	23.07M	170.7M	229.08M	267.12M	318.02M	361.06M	396.08M	430.23M	277.79M	312.36M	344.43M	348.33M	394.84M	432.27M	438.03M	441.47M	479.11M	452.8M	207.53M	209.73M	107.69M
Account Payables	1.23M	8.72M	12.44M	12.08M	11.57M	8.49M	5.18M	4.81M	5.48M	9.13M	9.83M	7.63M	7.18M	11.68M	2.34M	10.2M	7.89M	4.54M	6.97M	2.91M	2.03M
Deferred Revenue	n/a	n/a	n/a	n/a	13.4M	12.76M	10.38M	7.04M	12.86M	11.03M	9.3M	10M	15.72M	14.55M	11.39M	2.72M	5.63M	6.47M	4.96M	3.71M	2.79M
Short-Term Debt	1.1M	9.21M	9.15M	9.08M	9.02M	8.82M	8.84M	18.27M	n/a	9.72M	9.51M	9.43M	n/a	7M	5.08M	4.53M	4.5M	4.67M	2.81M	4.62M	2.14M
Other Current Liabilities	5.61M	14.7M	9.41M	7.75M	14.07M	13.62M	11.08M	7.59M	22.36M	11.14M	9.59M	10.29M	26.58M	14.87M	2.41M	3.25M	1.99M	320K	170K	63K	198K
Total Current Liabilities	7.94M	32.62M	30.99M	28.92M	34.66M	30.93M	25.1M	30.67M	27.84M	30M	28.93M	27.35M	33.76M	33.54M	21.23M	20.7M	20M	16.01M	14.91M	11.31M	7.16M
Long-Term Debt	n/a	101.49M	102.48M	103.45M	104.44M	105.34M	106.25M	97.92M	116.65M	108.37M	109.39M	85.45M	97M	90.95M	72.56M	48.48M	65.79M	25.45M	19.57M	12M	3.3M
Other Long-Term Liabilities	n/a	n/a	67K	101K	135K	586K	620K	654K	-8.26M	884K	630K	371K	-10.13M	438K	604K	650K	309K	331K	243.77M	263K	140.91M
Total Long-Term Liabilities	n/a	101.49M	102.55M	103.56M	104.58M	105.92M	106.87M	98.58M	108.39M	109.25M	110.03M	85.82M	86.87M	91.39M	73.16M	49.13M	66.1M	25.78M	263.33M	12.26M	144.22M
Total Liabilities	7.94M	134.11M	133.54M	132.47M	139.24M	136.86M	131.97M	129.25M	136.23M	139.25M	138.96M	113.17M	120.63M	124.93M	94.39M	69.83M	86.1M	41.79M	37.47M	23.57M	151.37M
Total Debt	1.1M	110.7M	111.63M	112.54M	113.46M	114.16M	115.09M	116.2M	116.65M	118.09M	118.9M	94.88M	97M	97.95M	77.64M	53.01M	70.29M	30.12M	22.38M	16.62M	5.44M
Common Stock	90K	90K	90K	90K	90K	90K	90K	89K	81K	81K	80K	80K	80K	80K	80K	80K	79K	79K	15K	67K	15K
Retained Earnings	-856.68M	-836.54M	-773.67M	-729.43M	-677.02M	-622M	-572.98M	-522.8M	-480.47M	-439.93M	-399.08M	-361.23M	-312.74M	-268.27M	-221.25M	-181.86M	-150.08M	-122.9M	-105.33M	-76.23M	-60.98M
Comprehensive Income	n/a	n/a	-122K	-57K	n/a	n/a	1K	7K	4K	32K	194K	531K	75K	166K	290K	81K	-29K	-19K	-27K	-45K	-584K
Shareholders Equity	15.13M	36.59M	95.54M	134.65M	178.78M	224.21M	264.11M	300.98M	141.56M	173.12M	205.47M	235.16M	274.21M	307.34M	343.64M	371.64M	393.01M	411.01M	170.07M	186.16M	-43.69M
Total Investments	4.07M	n/a	78.5M	78.41M	n/a	n/a	15.01M	42.56M	85.12M	132.73M	107.37M	96.87M	191.39M	215.08M	221.25M	186.41M	96.99M	54.09M	64.81M	56.15M	n/a